Lukáš Lafférs

Lukáš Lafférs

Auto-generated profile, based on publicly available information

Lukáš Lafférs

Department of Mathematics, Faculty of Natural Sciences, Matej Bel University, Banská Bystrica, Slovakia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in The Econometrics Journal
Verified
Journal Article
Closed access
PDF file
HFHelmut Farbmacher
Helmut Farbmacher
MHMartin Huber
Martin Huber
LLLukáš Lafférs
Lukáš Lafférs
HLHenrika Langen
Henrika Langen
MSMartin Spindler
Martin Spindler
This paper combines causal mediation analysis with double machine learning for a data-driven control of observed confounders in a high-dimensional setting. The average indirect effect of a binary treatment and the unmediated direct effect are estimated based on efficient score functions, which are robust w.r.t. misspecifications of the outcome, mediator, and treatment models. This property is key for selecting these models by double machine learning, which is combined with data splitting to prevent overfitting. We demonstrate that the effect estimators are asymptotically normal and n−1/2-consistent under specific regularity conditions and investigate the finite sample properties of the suggested methods in a simulation study when considering lasso as machine learner. We also provide an empirical application to the U.S. National Longitudinal Survey of Youth, assessing the indirect effect of health insurance coverage on general health operating via routine checkups as mediator, as well as the direct effect.

8 June 2022 in The Econometrics Journal
Verified
Journal Article
Closed access
PDF file
HBHugo Bodory
Hugo Bodory
MHMartin Huber
Martin Huber
LLLukáš Lafférs
Lukáš Lafférs
Summary: We consider evaluating the causal effects of dynamic treatments, i.e., of mul-tiple treatment sequences in various periods, based on double machine learning to control for observed, time-varying covariates in a data-driven way under a selection-on-observables assumption. To this end, we make use of so-called Neyman-orthogonal score functions, which imply the robustness of treatment effect estimation to moderate (local) misspecifications of the dynamic outcome and treatment models. This robustness property permits approximating outcome and treatment models by double machine learning even under high-dimensional covariates. In addition to effect estimation for the total population, we consider weighted estimation that permits assessing dynamic treatment effects in specific subgroups, e.g., among those treated in the first treatment period. We demonstrate that the estimators are asymptotically normal and $\sqrt{n}$-consistent under specific regularity conditions and investigate their finite sample properties in a simulation study. Finally, we apply the methods to the Job Corps study.

27 November 2023 in Journal of Business & Economic Statistics
Verified
Journal Article
Closed access
MBMichela Bia
Michela Bia
MHMartin Huber
Martin Huber
LLLukáš Lafférs
Lukáš Lafférs

15 June 2015 in Journal of Applied Econometrics
Verified
Journal Article
Closed access
PDF file
MHMartin Huber
Martin Huber
LLLukas Laffers
Lukas Laffers
GMGiovanni Mellace
Giovanni Mellace

29 June 2021 in Journal of Population Economics
Verified
Journal Article
Open access
PDF file
MKMartin Kahanec
Martin Kahanec
LLLukáš Lafférs
Lukáš Lafférs
BSBernhard Schmidpeter
Bernhard Schmidpeter
In the absence of effective vaccination, mass testing and quarantining of positive cases and their contacts could help to mitigate pandemics and allow economies to stay open. We investigate the effects of repeated mass testing on the COVID-19 pandemic caused by the SARS-CoV-2 virus, using data from the first ever nationwide rapid antigen testing implemented in Slovakia in autumn 2020. After the first round of testing, only districts above an ex ante unknown threshold of test positivity were re-tested. Comparing districts above and below the threshold, we provide evidence that repeated mass antigen testing can temporarily reduce the number of new infections. Our results suggest that mass testing coupled with the quarantining of positive cases and their contacts could be an effective tool in mitigating pandemics. For lasting effects, re-testing at regular intervals would likely be necessary.

1 January 2021 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
LSLubomir Skladany
Lubomir Skladany
PMPavol Molcan
Pavol Molcan
JVJana Vnencakova
Jana Vnencakova
PVPetra Vrbova
Petra Vrbova
Michael KuklaMichael Kukla
Michael Kukla
TKTomas Koller
Tomas Koller
Background. Physical frailty increases susceptibility to stressors and predicts adverse outcomes of cirrhosis. Data on disease course in different etiologies are scarce, so we aimed to compare the prevalence and risk factors of frailty and its impact on prognosis in nonalcoholic fatty liver (NAFLD) and alcoholic (ALD) cirrhosis. Patients and Methods. Cirrhosis registry RH7 operates since 2014 and includes hospitalized patients with decompensated cirrhosis, pre‐LT evaluation, or curable hepatocellular carcinoma (HCC). From the RH7, we identified 280 ALD and 105 NAFLD patients with at least 6 months of follow‐up. Results. Patients with NAFLD compared with ALD were older and had a higher proportion of females, higher body mass index (BMI) and mid‐arm circumference (MAC), lower MELD score, CRP, and lower proportion of refractory ascites. The liver frailty index did not differ, and the prevalence of HCC was higher (17.1 vs. 6.8%, p = 0.002). Age, sex, serum albumin, and C‐reactive protein (CRP) were independent predictors of frailty. In NAFLD, frailty was also associated with BMI and MAC and in ALD, with the MELD score. The Cox model adjusted for age, sex, MELD, CRP, HCC, and LFI showed that NAFLD patients had higher all‐cause mortality (HR = 1.88 95% CI 1.32–2.67, p < 0.001) and were more sensitive to the increase in LFI (HR = 1.51, 95% CI 1.05–2.2). Conclusion. Patients with NAFLD cirrhosis had a comparable prevalence of frailty compared to ALD. Although prognostic indices showed less advanced disease, NAFLD patients were more sensitive to frailty, which reflected their higher overall disease burden and led to higher all‐cause mortality.